Result Type

You Searched For: Cerium trichloride hydrate

71  results were found

~~Technical Bulletin X-Resin A4 VWR 110914.indd~~

Technical Bulletin X-Resin A4 VWR 110914.indd TECHNICAL BULLETIN This technical bulletin provides an overview of data generated from a comprehensive study conducted by MRIGlobal* a leading national research institute. The study design consisted of...

~~Technical Bulletin X-Resin A4 VWR 110914.indd~~

Technical Bulletin X-Resin A4 VWR 110914.indd TECHNICAL BULLETIN This technical bulletin provides an overview of data generated from a comprehensive study conducted by MRIGlobal* a leading national research institute. The study design consisted of...

~~Technical Bulletin X-Resin A4 VWR 110914.indd~~

Technical Bulletin X-Resin A4 VWR 110914.indd TECHNICAL BULLETIN This technical bulletin provides an overview of data generated from a comprehensive study conducted by MRIGlobal* a leading national research institute. The study design consisted of...

~~Technical Bulletin X-Resin A4 VWR 110914.indd~~

Technical Bulletin X-Resin A4 VWR 110914.indd TECHNICAL BULLETIN This technical bulletin provides an overview of data generated from a comprehensive study conducted by MRIGlobal* a leading national research institute. The study design consisted of...

~~Technical Bulletin X-Resin A4 VWR 110914.indd~~

Technical Bulletin X-Resin A4 VWR 110914.indd TECHNICAL BULLETIN This technical bulletin provides an overview of data generated from a comprehensive study conducted by MRIGlobal* a leading national research institute. The study design consisted of...

~~Technical Bulletin X-Resin A4 VWR 110914.indd~~

Technical Bulletin X-Resin A4 VWR 110914.indd TECHNICAL BULLETIN This technical bulletin provides an overview of data generated from a comprehensive study conducted by MRIGlobal* a leading national research institute. The study design consisted of...

~~Technical Bulletin X-Resin A4 VWR 110914.indd~~

Technical Bulletin X-Resin A4 VWR 110914.indd TECHNICAL BULLETIN This technical bulletin provides an overview of data generated from a comprehensive study conducted by MRIGlobal* a leading national research institute. The study design consisted of...

~~Technical Bulletin X-Resin A4 VWR 110914.indd~~

Technical Bulletin X-Resin A4 VWR 110914.indd TECHNICAL BULLETIN This technical bulletin provides an overview of data generated from a comprehensive study conducted by MRIGlobal* a leading national research institute. The study design consisted of...

~~Technical Bulletin X-Resin A4 VWR 110914.indd~~

Technical Bulletin X-Resin A4 VWR 110914.indd TECHNICAL BULLETIN This technical bulletin provides an overview of data generated from a comprehensive study conducted by MRIGlobal* a leading national research institute. The study design consisted of...

~~29188433AA Production of recombinant monoclonal an~~

1.0 0.9 0.8 0.7 0.6 0.5 rM A b (g /L ) 0.4 0.3 0.2 0.1 0 10 9 8 7 6 5 C el l d en si ty (c el ls /m L) 4 3 2 1 0 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 Time (d) Feed Application note 29188433 AA GE Healthcare Production of recombinant monoclonal antib...

~~29188433AA Production of recombinant monoclonal an~~

1.0 0.9 0.8 0.7 0.6 0.5 rM A b (g /L ) 0.4 0.3 0.2 0.1 0 10 9 8 7 6 5 C el l d en si ty (c el ls /m L) 4 3 2 1 0 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 Time (d) Feed Application note 29188433 AA GE Healthcare Production of recombinant monoclonal antib...

~~29188433AA Production of recombinant monoclonal an~~

1.0 0.9 0.8 0.7 0.6 0.5 rM A b (g /L ) 0.4 0.3 0.2 0.1 0 10 9 8 7 6 5 C el l d en si ty (c el ls /m L) 4 3 2 1 0 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 Time (d) Feed Application note 29188433 AA GE Healthcare Production of recombinant monoclonal antib...

~~29188433AA Production of recombinant monoclonal an~~

1.0 0.9 0.8 0.7 0.6 0.5 rM A b (g /L ) 0.4 0.3 0.2 0.1 0 10 9 8 7 6 5 C el l d en si ty (c el ls /m L) 4 3 2 1 0 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 Time (d) Feed Application note 29188433 AA GE Healthcare Production of recombinant monoclonal antib...

~~29188433AA Production of recombinant monoclonal an~~

1.0 0.9 0.8 0.7 0.6 0.5 rM A b (g /L ) 0.4 0.3 0.2 0.1 0 10 9 8 7 6 5 C el l d en si ty (c el ls /m L) 4 3 2 1 0 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 Time (d) Feed Application note 29188433 AA GE Healthcare Production of recombinant monoclonal antib...

29188433AA Production of recombinant monoclonal an

1.0 0.9 0.8 0.7 0.6 0.5 rM A b (g /L ) 0.4 0.3 0.2 0.1 0 10 9 8 7 6 5 C el l d en si ty (c el ls /m L) 4 3 2 1 0 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 Time (d) Feed Application note 29188433 AA GE Healthcare Production of recombinant monoclonal antib...

~~29188433AA Production of recombinant monoclonal an~~

1.0 0.9 0.8 0.7 0.6 0.5 rM A b (g /L ) 0.4 0.3 0.2 0.1 0 10 9 8 7 6 5 C el l d en si ty (c el ls /m L) 4 3 2 1 0 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 Time (d) Feed Application note 29188433 AA GE Healthcare Production of recombinant monoclonal antib...
1 - 16 of 71